EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Loss of Heterozygosity (LOH) Affecting HLA Genes in Breast Cancer: Clinical Relevance and Therapeutic Opportunities

María Antonia Garrido, Alba Navarro-Ocón, Víctor Ronco-Díaz, Nicolás Olea, Natalia Aptsiauri iD

Genes · 2024

DOI: 10.3390/genes15121542 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2024. Verfasst von María Antonia Garrido und 4 weiteren Autor:innen. Beteiligte Einrichtung: Radiology Service, Virgen de la Nieves University Hospital, 18014 Granada, Spain. Hauptthemen laut MEDLINE: Loss of Heterozygosity, Breast Neoplasms, HLA Antigens. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Innovation Spain, Andalusian Government and confounding by FEDER funds (, the Ministry of Science and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major histocompatibility complex (MHC) class-I molecules (or Human Leucocyte Antigen class-I) play a key role in adaptive immunity against cancer. They present specific tumor neoantigens to cytotoxic T cells and provoke an antitumor cytotoxic response. The total or partial loss of HLA molecules can inhibit the immune system’s ability to detect and destroy cancer cells. Loss of heterozygosity (LOH) is a common irreversible genetic alteration that occurs in the great majority of human tumors, including breast cancer. LOH at chromosome 6, which involves HLA genes (LOH-HLA), leads to the loss of an HLA haplotype and is linked to cancer progression and a weak response to cancer immunotherapy. Therefore, the loss of genes or an entire chromosomal region which are critical for antigen presentation is of particular importance in the search for novel prognostic and clinical biomarkers in breast cancer. Here, we review the role of LOH-HLA in breast cancer, its contribution to an understanding of cancer immune escape and tumor progression, and discuss how it can be targeted in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Loss of HeterozygosityBreast NeoplasmsHLA AntigensHumansFemaleTumor EscapeImmunotherapyClinical Relevance

Stichwörter der Autor:innen

HLA class-ILOH HLAbreast cancercancer immune escape

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • Radiology Service, Virgen de la Nieves University Hospital, 18014 Granada, Spain.
  • Department of Biochemistry, Molecular Biology III and Immunology, School of Medicine, University of Granada, 18016 Granada, Spain.
  • Biosanitary Research Institute of Granada (ibs.GRANADA), 18012 Granada, Spain.
  • Department of Genomic Medicine, Pfizer-University of Granada-Andalusian Regional Government Centre for Genomics and Oncological Research (GENYO), 18016 Granada, Spain.
  • Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016 Granada, Spain.
  • CIBER of Epidemiology and Public Health (CIBERSP), 28034 Madrid, Spain.

ORCID-Profile: Natalia Aptsiauri

Förderung

  • Ministry of Science and Innovation Spain
  • Andalusian Government and confounding by FEDER funds (
  • the Ministry of Science and Innovation
  • Andalusian Government

Zitieren

APA

Garrido, M. A., Navarro-Ocón, A., Ronco-Díaz, V., Olea, N., & Aptsiauri, N. (2024). Loss of Heterozygosity (LOH) Affecting HLA Genes in Breast Cancer: Clinical Relevance and Therapeutic Opportunities. Genes. https://doi.org/10.3390/genes15121542

Vancouver

Garrido MA, Navarro-Ocón A, Ronco-Díaz V, Olea N, Aptsiauri N. Loss of Heterozygosity (LOH) Affecting HLA Genes in Breast Cancer: Clinical Relevance and Therapeutic Opportunities. Genes. 2024. doi:10.3390/genes15121542

BibTeX
@article{Garrido2024,
  author = {Garrido, María Antonia and Navarro-Ocón, Alba and Ronco-Díaz, Víctor and Olea, Nicolás and Aptsiauri, Natalia},
  title = {Loss of Heterozygosity (LOH) Affecting HLA Genes in Breast Cancer: Clinical Relevance and Therapeutic Opportunities},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15121542}
}
Kostenlos starten →